Patents matching “The United States of America as represented by the Secretary of the Army”

US 7018636

Vaccine against Gram-negative bacterial infections

The United States of America as represented by the Secretary of the Army · Granted Mar 28, 2006 · Expires Mar 23, 2026

US 6984504

Ebola virion proteins expressed from venezuelan equine encephalitis (VEE) virus replicons

The United States of America as represented by the Secretary of the Army · Granted Jan 10, 2006 · Expires Jan 5, 2026

US 6951846

Artemisinins with improved stability and bioavailability for therapeutic drug development and application

The United States of America as represented by the Secretary of the Army · Granted Oct 4, 2005 · Expires Sep 29, 2025

US 6939546

Model for testing immunogenicity of peptides

The United States of America as represented by the Secretary of the Army · Granted Sep 6, 2005 · Expires Sep 1, 2025

US 6902743

Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix

The United States of America as represented by the Secretary of the Army · Granted Jun 7, 2005 · Expires Jun 2, 2025

US 6875433

Monoclonal antibodies and complementarity-determining regions binding to Ebola glycoprotein

The United States of America as represented by the Secretary of the Army · Granted Apr 5, 2005 · Expires Mar 31, 2025

US 6872398

Conjugate vaccine against gram-negative bacterial infections

The United States of America as represented by the Secretary of the Army · Granted Mar 29, 2005 · Expires Mar 24, 2025

US 6869602

Method for treating, preventing, or inhibiting enterotoxigenic Escherichia coli infections with bovine red blood cells

The United States of America as represented by the Secretary of the Army · Granted Mar 22, 2005 · Expires Mar 17, 2025

US 6869787

Ricin vaccine and methods of making and using thereof

The United States of America as represented by the Secretary of the Army · Granted Mar 22, 2005 · Expires Mar 17, 2025

US 6855322

Isolation and purification of P. falciparum merozoite protein-142 vaccine

The United States of America as represented by the Secretary of the Army · Granted Feb 15, 2005 · Expires Feb 10, 2025

US 6855331

Sustained release hydrophobic bioactive PLGA microspheres

The United States of America as represented by the Secretary of the Army · Granted Feb 15, 2005 · Expires Feb 10, 2025

US 6844010

Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix

The United States of America as represented by the Secretary of the Army · Granted Jan 18, 2005 · Expires Jan 13, 2025

US 6825323

Compositions for treatment of hemorrhaging with activated factor VIIa in combination with fibrinogen and methods of using same

The United States of America as represented by the Secretary of the Army · Granted Nov 30, 2004 · Expires Nov 25, 2024

US 6815425

Pharmaceutical composition containing pGLU-GLU-PRO-NH2 and method for treating diseases and injuries to the brain, spinal cord and retina using same

The United States of America as represented by the Secretary of the Army · Granted Nov 9, 2004 · Expires Nov 4, 2024

US 6797276

Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response

The United States of America as represented by the Secretary of the Army · Granted Sep 28, 2004 · Expires Sep 23, 2024

US 6770479

Anthrax vaccine

The United States of America as represented by the Secretary of the Army · Granted Aug 3, 2004 · Expires Jul 29, 2024

US 6716450

Enhancing protein activity through nanoencapsulation

The United States of America as represented by the Secretary of the Army · Granted Apr 6, 2004 · Expires Apr 1, 2024

US 6713444

Buforin I as a specific inhibitor and therapeutic agent for botulinum toxin B and tetanus neurotoxins

The United States of America as represented by the Secretary of the Army · Granted Mar 30, 2004 · Expires Mar 25, 2024

US 6713284

Bacterial superantigen vaccines

The United States of America as represented by the Secretary of the Army · Granted Mar 30, 2004 · Expires Mar 25, 2024

US 6706754

Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis

The United States of America as represented by the Secretary of the Army · Granted Mar 16, 2004 · Expires Mar 11, 2024

US 6680374

Invaplex from gram negative bacteria, method of purification and methods of use

The United States of America as represented by the Secretary of the Army · Granted Jan 20, 2004 · Expires Jan 15, 2024

US 6641815

Sequestrin

The United States of America as represented by the Secretary of the Army · Granted Nov 4, 2003 · Expires Oct 30, 2023

US 6638514

Multivalent dengue virus vaccine

The United States of America as represented by the Secretary of the Army · Granted Oct 28, 2003 · Expires Oct 23, 2023

US 6632640

Vaccine against Staphylococcus intoxication

The United States of America as represented by the Secretary of the Army · Granted Oct 14, 2003 · Expires Oct 9, 2023